$PGNY News

New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

What Does Progyny's Falling Multiple Really Say?

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock?

Why Are Progyny (PGNY) Shares Soaring Today

Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics

Progyny (NASDAQ:PGNY): A Quality Investing Watchlist Candidate

Progyny (PGNY) Stock Looks Fairly Valued Despite Its 57% Five Year Slide

Progyny: Best-In-Class And Likely To Exceed Analyst Estimates In 2027

Options Movement At Progyny: KEVIN GORDON Exercises Worth $325K

Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2

Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know

Citizens Maintains Market Outperform on Progyny, Raises Price Target to $33

Progyny: Slow But Consistent Growth With A Pristine Balance Sheet

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

Progyny (NASDAQ:PGNY): An Affordable Growth Stock With Strong Earnings and Reasonable Valuation

Wells Fargo Conceives a High Rating for the Fertility-Benefits Biz

JP Morgan Maintains Neutral on Progyny, Raises Price Target to $30

Wells Fargo Initiates Coverage On Progyny with Overweight Rating, Announces Price Target of $37